A Randomized Study to Evaluate the Efficacy of Ingenol Mebutate on Actinic Keratoses and Field Cancerization Compared to Cryotherapy
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 10 Jan 2018
At a glance
- Drugs Ingenol mebutate (Primary)
- Indications Actinic keratosis
- Focus Therapeutic Use
- 04 Jan 2018 Status changed from recruiting to active, no longer recruiting.
- 07 Aug 2017 Status changed from not yet recruiting to recruiting.
- 02 May 2017 Planned initiation date changed from 1 Mar 2017 to 1 Jun 2017.